INTRODUCTION
One of the most common methods employed these days for the restoration of missing teeth is by dental implants. A significant advancement in the design of implants and modifications in the procedure of dental implant surgery have led the surgeons in reaching the success rate of dental implants to approximately 95%. 1 One of the most important factors for full successful placement of dental implants is osseointegration. Any defect in osseointegration can lead to failure of dental implant. Success of dental implants also depends on a number of body's metabolic factors. One such factor or condition affecting the success of dental implants is the diabetes. Diabetes mellitus is a chronic disease leading to the state of hyperglycemia
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and further complications involving multiple organs and tissues, including the interruption in the physiological process of wound healing. 2, 3 Hence, we assessed the clinicomicrobial and salivary profile of diabetic patients undergoing rehabilitation by dental implants.
MATERIALS AND METHODS
This study was conducted in the oral implantology section of the institution and included all diabetic patients who underwent dental implant surgeries for prosthetic rehabilitation. Ethical approval was taken from the Institutional Ethical Committee and written consent was obtained from the patients enrolled in the study after explaining to them the entire research protocol.
Patients with age below 20 years or above 45 years, with a history of any other systemic illness apart from diabetes, affected by any blood disorders, any history of previous major or minor surgical procedure in the same region, or any known drug allergy were excluded from this study.
The patients with any acute infectious or inflammatory conditions were also excluded from this study. Other groups of patients who recovered dental implants and with same selection and exclusion criteria but with the absence of diabetes were also assessed as control groups.
Only those patients were included in whom follow-up record of a minimum of 1 year could be maintained.
Complete intraoral clinical examination of the patients was done. Measuring of periodontal probing depth (PPD), the level of free gingival margin, attachment level (AL) clinically, and bleeding elicited on probing (BP) of the tooth and the implant sites was done. Plaque index was also calculated following the criteria of Haffajee et al. 4 Follow-up examination was done at baseline and at various time intervals up to 1 year. Intraoral periapical radiographs were taken for assessment of radiographic changes. Mesial and distal surfaces of both the tooth and the dental implant were taken as standard for measurement of the linear bone levels. Cementoenamel junction, restoration of apicalmost borders and junction of crown to the abutment in cases of dental implants were used as standard points for measuring height of the alveolar bone at different follow-up time intervals. At the screening time, baseline, and 1 year follow-up time, 25 mL of salivary sample was taken from all the subjects and was sent to the laboratories for the assessment of the following biomarkers: Interleukins, matrix metalloproteinase, and osteoprotegerin (OP). Sandwich enzyme-linked immunosorbent assay was used for evolution of protein biomarkers. Mesial surfaces of implants and nearby teeth were used to extract the plaque biofilms at subgingival levels at various follow-up time intervals. Biofilm was harvested with the use of a sterile Gracey curette. All the samples were sent to the laboratory for microbial growth assessment. Quantitative polymerase chain reaction was used to detect various components of microbial flora as described by Mullally et al. 5 Statistical Package for the Social Sciences software was used for the assessment of all the results. Chi-square test, paired t test, and one-way analysis of variance were used for assessing the level of significance; p < 0.05 was taken as significant.
RESULTS
Graph 1 shows the mean levels of IL-β during follow-up time. At baseline time, the mean level of IL-β was found to be 2.38 and 2.21 in diabetic group and control group respectively. At 6 months follow-up time, the mean value of IL-β was found to be 2.32 and 2.23 in diabetic and control group respectively. Graph 2 highlights the mean levels of OP (log 10 pg/mL) during follow-up time. Significant correlation was observed in the levels of OP between the diabetic group and control group. Graph 3 shows the demographic details of the patients.
Graph 1:
Mean levels of IL-β (log 10 pg/mL) during follow-up time Graph 2: Mean levels of OP (log 10 pg/mL) during follow-up time
Mean age of the patients in diabetic and control group were 62 and 61 years respectively. Table 1 shows the clinicoradiographic parameters of teeth and implants. Significant alteration was obtained while comparing the mean PPD, mean AL, mean BP, and mean plaque index values between the two study groups. Table 2 shows the qualitative assessment of the predominant microbial flora in the two study groups. No significant correlation was obtained while comparing the microbial flora of diabetic and control group.
DISCUSSION
Number of diabetic patients, in the recent Indian and Chinese studies, has surpassed the estimated figures given by the International Diabetes Foundation in 2009. 6, 7 Dental implants have become increasingly popular over the last few decades because of the comfort provided by them in comparison to the fixed partial dentures and removable partial dentures. [8] [9] [10] [11] One of the reasons that has popularized dental implant treatment in the present world's scenario is the growing economy of the developing countries. Diabetes is one of the commonly observed conditions affecting major proportion of the world. Problems may be 2.67* *Significant difference in intragroup over follow-up time; **significant difference between the two study groups at the same follow-up time; ***significant difference between the two groups when compared overall Graph 3: Demographic details of the patients 1.74 *Significant difference between the study groups at baseline time of follow-up; **significant difference between the study groups at 1 year time of follow-up encountered by the clinician while planning dental implant surgeries in diabetic patients. 12 Hence, we assessed the clinicomicrobial and salivary profile of diabetic patients undergoing rehabilitation by dental implants. While evaluating the mean levels of IL-β during follow-up time, no significant correlation was obtained between the control group and diabetic group (p > 0.05) (Graph 1). Significant reduction in the mean values of OP was seen between the baseline time and the follow-up time between the control group and the diabetic group (p < 0.05) (Graph 2). Similar results were reported in the studies of Costa et al 13 and O'Sullivan et al. 14 World
Health Organization (WHO) reported similar findings in their studies. For the prevention of further vascular destruction by mediators of inflammation, Schoppet et al 15 hypothesized that vascular system releases OP as a part of the compensatory mechanism. Mean AL loss seen in our study was comparable to the results seen in previous studies by Schätzle et al. 16 As far as radiographic changes are concerned, similar results have been obtained, which correlate with the results of past studies. 17 No significant differences were observed in the pattern and quantitative analysis of microbial flora in the two study groups. These results collaborated with the previous results of Yuan et al. 18 Moreover, WHO also reported similar findings. Feloutzis et al 19 evaluated
osseointegrated international team for implantology [ITI(R)] dental implants to investigate the association of specific IL-1 gene polymorphisms and peri-implant bone loss. They evaluated 90 consecutive Caucasian patients who were treated with minimum of a single ITI implant and observed that more than 30% of them were positive for IL-1. From the results, they concluded that a higher risk of peri-implant bone loss is associated with heavy smoking. Annibali et al 20 evaluated the 1 year survival of dental implants in diabetic patients. They conducted an electronic search of the Cochrane Oral Health Group's Trials Register, Medline, and EMBASE for assessing the survival rate of dental implants in patients suffering from diabetes. They observed a mean cumulative survival rate of around 0.96 before loading of dental implant, while after 1 year follow-up, it was found to be 0.91. From the results, they concluded that an increasing trend of dental implant failure is observed in diabetic patients during the first year of loading of dental implants. Al Amri et al 21 compared the clinicoradiographic variables around short length and long length dental implants in patients with and without diabetes. They evaluated a total of 47 patients who underwent dental implant therapy in mandibular posterior regions. They divided all the patients broadly into two groups. One group included patients with diabetes and other without diabetes. They observed no statistically significant difference in probing depth, bleeding on probing, and other clinical parameters in patients in the two study groups. From the results, they concluded that similar clinicoradiographic stability is exhibited by short implants in comparison to long implants. Shi et al 22 assessed whether dental implant failure rate differed in diabetic patients and in patients with controlled diabetes. They made a PubMed, the Cochrane Library, and Clinical Trials.gov search and evaluated those studies which highlighted the failure of dental implant in diabetic patients. They observed no direct association between glycemic levels of the patients and failure rate of dental implants.
From the results, they conclude that in patients with controlled and uncontrolled diabetes, no significant difference exists. Nobre Mde et al 23 investigated the prognosis of immediate function of dental implant rehabilitation in diabetic patients with a history of any cardiovascular disease. They retrospectively analyzed 70 diabetic patients in which a total of 352 dental implants were placed. They observed a survival rate of more than 95%, which resulted in a nonsignificant alteration between the patients with and without diabetes. From the results, they concluded that presence or absence of cardiovascular diseases has no effect on survival of dental implants. DeLuca and Zarb 24 evaluated the effect of cigarette smoking on the failure and survival of dental implants and peri-implant bone loss. They evaluated a total of 235 patients in which a total of 767 Brånemark implants of dental implants were placed. They observed a positive correlation between smoking and peri-implant bone loss. From the results, they concluded that in patients undergoing dental implants and having a long-term history of cigarette smoking should be made aware of consequences and effect of smoking on the desorption of bone around the peri-implant area. Conte et al 25 assessed the effect of diabetes on the bone-related gene expression in the areas receiving dental implants. They evaluated a total of 54 patients and observed a low quantity of bone sialoprotein, type I collagen in patients with poorly controlled diabetes.
CONCLUSION
Authors concluded that similar microbial, salivary marker, and clinicoradiological patterns are seen in nondiabetic patients and in diabetic patients who have maintained their metabolic activities. Further studies on a longer scale need to be conducted for establishing certain concrete guidelines in this field.
